Acute effect of dopamine agonists and some antidepressants in stress-induced deficit of fighting behavior

Polish Journal of Pharmacology

Volumn 48, Issue 4, 1996, Pages 403-408

  Ossowska, Grazyna ^a   Klenk Majewska, Bozena ^a   Zebrowska Łupina, Iwona ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

apomorphine; chronic stress; electric footshock induced fighting behavior; imipramine; nomifensine; quinpirole; selegiline

Indexed keywords

ANTIDEPRESSANT AGENT; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; IMIPRAMINE; NOMIFENSINE; QUINPIROLE; SELEGILINE;

AGGRESSIVENESS; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ELECTRIC SHOCK; EXPLORATORY BEHAVIOR; FIGHTING; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; RAT; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

AGGRESSION; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; APOMORPHINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; EXPLORATORY BEHAVIOR; IMIPRAMINE; MALE; MONOAMINE OXIDASE INHIBITORS; NOCICEPTORS; NOMIFENSINE; QUINPIROLE; RATS; RATS, WISTAR; SELEGILINE; STRESS;

EID: 0029911995     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Allain H., Reymann J. M., Bentue-Ferrer D., Pape D., van de Driessche J., Sabouraud O.: The use of bromocriptine for testing central dopaminergic reactivity. Psychopharmacology, 1980, 70, 313-315.
2. Bliss E-L., Allion J.: Relationship of stress and activity to brain dopamine and homovanillic acid. Life Sci., 1971, 10, Part I, 1161-1169.
3. Borsini F., Lecci A., Mancinelli A., D'Aranno V., Meli A.: Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity. Eur. J. Pharmacol., 1988, 148, 301-307.
4. Cabib S., Kempf E., Schleef C., Mele A., PuglisiAllegra S.: Different effects of acute and chronic stress on two dopamine-mediated behaviors in the mouse. Physiol. Behav., 1988, 43, 223-227.
5. Cabib S., Kempf E., Schleef C., Oliverio A., PuglisiAllegra S.: Effects of immobilization stress on dopamine and its metabolites in different brain areas of the mouse: role of genotype and stress duration. Brain Res., 1988, 441, 153-160.
6. Costall B., Naylor R. J.: Further aspects of nomifensine pharmacology. Brit. J. Clin. Pharmacol., 1972, 4, (Suppl. 2), 89s-99S.
7. Del Zompo M., Bocchetta A., Bernardi F., Burral G., Corsini G. U.: Clinical evidence for a role of dopaminergic system in depressive syndromes. Advan. Biosci., 1990, 77, 177-184.
8. Duterte-Boucher D., Lecrelc J. F., Panissaud C., Costentin J.: Acute effects of direct dopamine agonists in the mouse behavioral despair test. Eur. J. Pharmacol., 1988, 183-190.
9. Eilam D., Szechtman H.: Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur. J. Pharmacol., 1989, 161, 151-157.
10. Fibiger H. C., Philips A. G., Blaha C. D.: Dopamine and the neural substrates of reward: implications for the mechanisms of action of antidepressant drugs. Advan. Biosci., 1990, 77, 51-62.
11. Fontenay M., Le Cornec J., Zaczyńska M., Debarle M. C., Simon P., Boissier J. R.: Problèmes posés par l'utilisation de trois tests de comportement du rat pour l'étude des médicaments psychotropes. J. Pharmacol. (Paris), 1970, 1, 243-254.
12. Fride E., Weinstock M.: Alterations in behavioral and striatal dopamine asymmetries induced by prenatal stress. Pharmacol. Biochem. Behav., 1989, 32, 425-430.
13. Glavin G. B., Dugani A. M., Pinsky C.: L-Deprenyl attenuates stress ulcer formation in rats. Neurosci. Lett, 1986, 70, 379-381.
14. Grof P., Saxena B., Daigle L., Mahutte G.: Dopaminergic agonist nomifensine compared with amitriptyline. A double-blind clinical trial in acute primary depression. Psychopharmacology, 1977, 53, 309-312.
15. Hoffman J.: Pharmacology of nomifensine. Int. Pharmacopsychiat., 1982, 17 (Suppl 1), 4-20.
16. Katz R. J., Hersh S.: Amitriptyline and scopolamine in animal model of depression. Neurosci. Biobehav. Rev., 1981, 5, 265-271.
17. Katz R. J., Roth K. A., Carroll B. J.: Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci. Biobehav. Rev., 1981, 5, 247-251.
18. Katz R. J., Sibel M.: Animal model of depression: tests of three structurally and pharmacologically novel antidepressant compounds. Pharmacol. Biochem. Behav., 1982, 16, 973-977.
19. Knoll J., Dallo J., Yen T. T.: Striatal dopamine, sexual activity and lifespan longevity of rats treated with (-) deprenyl. Life Sci., 1989, 45, 525-531.
20. Mann J., Gershon S.: L-deprenyl, a selective monoamine oxidase typ-B inhibitor in endogenous depression. Life Sci., 1980, 26, 877-882.
21. Moreau J. L., Fenck F., Martin J. R., Mortas P., Haefely W. E.: Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur. Neuropsychopharmacol., 1992, 2, 43-49.
22. Muscat R., Sampson D., Willner P.: Dopaminergic mechanism of imipramine action in an animal model of depression. Biol. Psychiat., 1990, 28, 223-230.
23. Ossowska G., Klenk-Majewska B., Łupina T.: The effect of calcium channel antagonists on the aggressive behavior in chronically stressed rats. Pol. J. Pharmacol., 1994, 46, 403-408.
24. Papp M., Muscat R., Willner P.: Additive effects of chronic treatment with antidepressant drugs and intermittent treatment with a dopamine agonists. Eur. Neuropsychopharmacol., 1992, 2, 121-125.
25. Papp M., Willner P., Muscat R.: Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia. Psychopharmacology, 1993, 110, 159-164.
26. Post R. M., Gerner R. H., Carman J. S., Gillin J. C., Jimerson D. C., Goodwin F. K., Bunney W. E.: Effects of a dopamine agonist piribedil in depressed patients. Arch. Gen. Psychiat., 1978, 36, 609-615.
27. Sokoloff P., Giros B., Martres M. P., Bouthenet M. L., Schwartz J. C.: Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature, 1990, 357, 146-151.
28. Tedeschi D. H., Fowler P. J., Miller R. B., Macko E.: Pharmacological analysis of footshock-induced fighting behaviour. In: Aggressive Behaviour. Eds. Garattini S., Sigg K., Excerpta Medica, Amsterdam, 1969, 245-252.
29. Thierry A. M., Tassin J. P., Blanc G., Glowinski J.: Selective activation of the mesocortical DA system by stress. Nature, 1976, 263, 242-244.
30. Weiss J. M., Goodman P. A., Losito B. G., Corrigan S., Charry J. M., Bailey W. H.: Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine and serotonin levels in various regions of rat brain. Brain Res. Rev., 1981, 3, 167-205.
31. Weiss J. M., Goodman P. A., Simson P.: Neurochemical mechanisms underlying stress-induced depression. In: Stress and Coping. Eds. Field T., Schneiderman P., Lawrance-Erlbaum, Hillsdale, N. Y., 1985, 1, 93-116.
32. Willner P.: Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res. Rev., 1983, 6, 211-224.
33. Willner P., Lappas S., Cheeta S., Muscat R.: Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology, 1994, 115, 454-462.
34. Wachrens J., Gerlach J.: Bromocriptine and imipramine in endogeneus depression: a double blind controlled trial in out-patients. J. Affect. Disorders, 1981, 3, 193-202.
35. Żebrowska-Łupina I., Ossowska G., Klenk-Majewska B.: Chronic stress reduced fighting behavior of rats: The effect of antidepressants. Pharmacol. Biochem. Behav., 1991, 39, 293-296.
36. Żebrowska-Łupina I., Ossowska G., Klenk-Majewska B.: The influence of antidepressants on the aggressive behavior in stressed rats: the role of dopamine. Pol. J. Pharmacol. Pharm., 1992, 44, 325-336.